Header and Body 4

Advantages

  • Cancer-related ECM signatures identifies targets that are significantly enriched in tumors compared to normal tissue, which can be used to diagnose and prognose cancer
  • Proteins in ECM signatures can be targeted using conjugated antibodies, thus, limiting systemic exposure